Business News
Guardant Health Japan receives regulatory approval of Guardant360® CDx liquid biopsy as companion diagnostic for amivantamab-vmjw to identify patients with inoperable or recurrent NSCLC harbouring EGFR exon 20 insertion mutations, Business News
Japan's Ministry of Health, Labour and Welfare has approved Guardant360® CDx as the first blood-based companion diagnostic in Japan for EGFR exon 20 insertion…